Yapali, S. 2021. EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN HEPATITIS B VIRUS-INFECTED PATIENTS WITH CHRONIC HEMODIALYSIS AND RENAL TRANSPLANTATION: A PRELIMINARY RESULT. AASLD THE LIVER MEETİNG DIGITAL EXPERIENCE , 480-481.

Yapali, S., (2021). EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN HEPATITIS B VIRUS-INFECTED PATIENTS WITH CHRONIC HEMODIALYSIS AND RENAL TRANSPLANTATION: A PRELIMINARY RESULT . AASLD THE LIVER MEETİNG DIGITAL EXPERIENCE (pp.480-481).

Yapali, Suna. "EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN HEPATITIS B VIRUS-INFECTED PATIENTS WITH CHRONIC HEMODIALYSIS AND RENAL TRANSPLANTATION: A PRELIMINARY RESULT," AASLD THE LIVER MEETİNG DIGITAL EXPERIENCE, 2021

Yapali, Suna. "EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN HEPATITIS B VIRUS-INFECTED PATIENTS WITH CHRONIC HEMODIALYSIS AND RENAL TRANSPLANTATION: A PRELIMINARY RESULT." AASLD THE LIVER MEETİNG DIGITAL EXPERIENCE , pp.480-481, 2021

Yapali, S. (2021) . "EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN HEPATITIS B VIRUS-INFECTED PATIENTS WITH CHRONIC HEMODIALYSIS AND RENAL TRANSPLANTATION: A PRELIMINARY RESULT." AASLD THE LIVER MEETİNG DIGITAL EXPERIENCE , pp.480-481.

@conferencepaper{conferencepaper, author={Suna YAPALI}, title={EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN HEPATITIS B VIRUS-INFECTED PATIENTS WITH CHRONIC HEMODIALYSIS AND RENAL TRANSPLANTATION: A PRELIMINARY RESULT}, congress name={AASLD THE LIVER MEETİNG DIGITAL EXPERIENCE}, city={}, country={}, year={2021}, pages={480-481} }